-
1
-
-
13144281703
-
Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis
-
DOI 10.1073/pnas.95.22.13018
-
Cases, S.; Smith, S. J.; Zheng, Y.-W.; Myers, H. M.; Lear, S. R.; Sande, E.; Novak, S.; Collins, C.; Welch, C. B.; Lusis, A. J.; Erickson, S. K.; Farese, R. V., Jr. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 13018-13023 (Pubitemid 28509516)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.22
, pp. 13018-13023
-
-
Cases, S.1
Smith, S.J.2
Zheng, Y.-W.3
Myers, H.M.4
Lear, S.R.5
Sande, E.6
Novak, S.7
Collins, C.8
Welch, C.B.9
Lusis, A.J.10
Erickson, S.K.11
Farese Jr., R.V.12
-
2
-
-
0035914356
-
Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members
-
Cases, S.; Stone, S. J.; Zhou, P.; Yen, E.; Tow, B.; Lardizabal, K. D.; Voelker, T.; Farese, R. V., Jr. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members J. Biol. Chem. 2001, 276, 38870-38876
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 38870-38876
-
-
Cases, S.1
Stone, S.J.2
Zhou, P.3
Yen, E.4
Tow, B.5
Lardizabal, K.D.6
Voelker, T.7
Farese, Jr.R.V.8
-
3
-
-
36549079637
-
Antisense and small-molecule modulation of diacylglycerol acyltransferase
-
DOI 10.1517/13543776.17.11.1331
-
Hubbard, B. K.; Enyedy, I.; Gilmore, T. A.; Serrano-Wu, M. H. Antisense and small-molecule modulation of diacylglycerol acyltransferase Expert Opin. Ther. Pat. 2007, 17, 1331-1339 (Pubitemid 350186588)
-
(2007)
Expert Opinion on Therapeutic Patents
, vol.17
, Issue.11
, pp. 1331-1339
-
-
Hubbard, B.K.1
Enyedy, I.2
Gilmore, T.A.3
Serrano-Wu, M.H.4
-
4
-
-
77954647349
-
DGAT1 inhibitors as anti-obesity and anti-diabetic agents
-
Birch, A. M.; Buckett, L. K.; Turnbull, A. V. DGAT1 inhibitors as anti-obesity and anti-diabetic agents Curr. Opin. Drug Discovery Dev. 2010, 13, 489-96
-
(2010)
Curr. Opin. Drug Discovery Dev.
, vol.13
, pp. 489-496
-
-
Birch, A.M.1
Buckett, L.K.2
Turnbull, A.V.3
-
6
-
-
84863115587
-
Identification and Preliminary Characterization of a Potent, Safe, and Orally Efficacious Inhibitor of Acyl-CoA:Diacylglycerol Acyltransferase 1
-
Yeh, V. S.; Beno, D. W.; Brodjian, S.; Brune, M. E.; Cullen, S. C.; Dayton, B. D.; Dhaon, M. K.; Falls, H. D.; Gao, J.; Grihalde, N.; Hajduk, P.; Hansen, T. M.; Judd, A. S.; King, A. J.; Klix, R. C.; Larson, K. J.; Lau, Y. Y.; Marsh, K. C.; Mittelstadt, S. W.; Plata, D.; Rozema, M. J.; Segreti, J. A.; Stoner, E. J.; Voorbach, M. J.; Wang, X.; Xin, X.; Zhao, G.; Collins, C. A.; Cox, B. F.; Reilly, R. M.; Kym, P. R.; Souers, A. J. Identification and Preliminary Characterization of a Potent, Safe, and Orally Efficacious Inhibitor of Acyl-CoA:Diacylglycerol Acyltransferase 1 J. Med. Chem. 2012, 55, 1751-1757
-
(2012)
J. Med. Chem.
, vol.55
, pp. 1751-1757
-
-
Yeh, V.S.1
Beno, D.W.2
Brodjian, S.3
Brune, M.E.4
Cullen, S.C.5
Dayton, B.D.6
Dhaon, M.K.7
Falls, H.D.8
Gao, J.9
Grihalde, N.10
Hajduk, P.11
Hansen, T.M.12
Judd, A.S.13
King, A.J.14
Klix, R.C.15
Larson, K.J.16
Lau, Y.Y.17
Marsh, K.C.18
Mittelstadt, S.W.19
Plata, D.20
Rozema, M.J.21
Segreti, J.A.22
Stoner, E.J.23
Voorbach, M.J.24
Wang, X.25
Xin, X.26
Zhao, G.27
Collins, C.A.28
Cox, B.F.29
Reilly, R.M.30
Kym, P.R.31
Souers, A.J.32
more..
-
7
-
-
79953801433
-
Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes
-
Qian, Y.; Wertheimer, S. J.; Ahmad, M.; Cheung, A. W.-H.; Firooznia, F.; Hamilton, M. M.; Hayden, S.; Li, S.; Marcopulos, N.; McDermott, L.; Tan, J.; Yun, W.; Guo, L.; Pamidimukkala, A.; Chen, Y.; Huang, K.-S.; Ramsey, G. B.; Whittard, T.; Conde-Knape, K.; Taub, R.; Rondinone, C. M.; Tilley, J.; Bolin, D. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5- trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes J. Med. Chem. 2011, 54, 2433-2446
-
(2011)
J. Med. Chem.
, vol.54
, pp. 2433-2446
-
-
Qian, Y.1
Wertheimer, S.J.2
Ahmad, M.3
Cheung, A.W.-H.4
Firooznia, F.5
Hamilton, M.M.6
Hayden, S.7
Li, S.8
Marcopulos, N.9
McDermott, L.10
Tan, J.11
Yun, W.12
Guo, L.13
Pamidimukkala, A.14
Chen, Y.15
Huang, K.-S.16
Ramsey, G.B.17
Whittard, T.18
Conde-Knape, K.19
Taub, R.20
Rondinone, C.M.21
Tilley, J.22
Bolin, D.23
more..
-
8
-
-
64349101065
-
Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor
-
references cited therein.
-
Birch, A. M.; Birtles, S.; Buckett, L. K.; Kemmitt, P. D.; Smith, G. J.; Smith, T. J. D.; Turnbull, A. V.; Wang, S. J. Y. Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor J. Med. Chem. 2009, 52, 1558-1568 and references cited therein.
-
(2009)
J. Med. Chem.
, vol.52
, pp. 1558-1568
-
-
Birch, A.M.1
Birtles, S.2
Buckett, L.K.3
Kemmitt, P.D.4
Smith, G.J.5
Smith, T.J.D.6
Turnbull, A.V.7
Wang, S.J.Y.8
-
9
-
-
14744304497
-
Inhibition of triglyceride synthesis as a treatment strategy for obesity: Lessons from DGAT1-deficient mice
-
DOI 10.1161/01.ATV.0000151874.81059.ad
-
Chen, H. C.; Farese, R. V., Jr. Inhibition of triglyceride synthesis as a treatment strategy for obesity, lessons from DGAT1-deficient mice Arterioscler., Thromb., Vasc. Biol. 2005, 25, 482-486 (Pubitemid 40330925)
-
(2005)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.25
, Issue.3
, pp. 482-486
-
-
Chen, H.C.1
Farese Jr., R.V.2
-
10
-
-
0034103658
-
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat
-
DOI 10.1038/75651
-
Smith, S. J.; Cases, S.; Jensen, D. R.; Chen, H. C.; Sande, E.; Tow, B.; Sanan, D. A.; Raber, J.; Eckel, R. H.; Farese, R. V., Jr. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking DGAT Nat. Genet. 2000, 25, 87-90 (Pubitemid 30257043)
-
(2000)
Nature Genetics
, vol.25
, Issue.1
, pp. 87-90
-
-
Smith, S.J.1
Cases, S.2
Jensen, D.R.3
Chen, H.C.4
Sande, E.5
Tow, B.6
Sanan, D.A.7
Raber, J.8
Eckel, R.H.9
Farese Jr., R.V.10
-
11
-
-
0036228339
-
Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1
-
DOI 10.1172/JCI200214672
-
Chen, H. C.; Smith, S. J.; Ladha, Z.; Jensen, D. R.; Ferreira, L. D.; Pulawa, L. K.; McGuire, J. G.; Pitas, R. E.; Eckel, R. H.; Farese, R. V., Jr. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1 J. Clin. Invest. 2002, 109, 1049-1055 (Pubitemid 34413589)
-
(2002)
Journal of Clinical Investigation
, vol.109
, Issue.8
, pp. 1049-1055
-
-
Chen, H.C.1
Smith, S.J.2
Ladha, Z.3
Jensen, D.R.4
Ferreira, L.D.5
Pulawa, L.K.6
McGuire, J.G.7
Pitas, R.E.8
Eckel, R.H.9
Farese Jr., R.V.10
-
12
-
-
0037067721
-
DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis
-
DOI 10.1074/jbc.M202013200
-
Buhman, K. K.; Smith, S. J.; Stone, S. J.; Repa, J. J.; Wong, J. S.; Knapp, F. F., Jr.; Burri, B. J.; Hamiltons, R. L.; Abumrad, N. A.; Farese, R. V., Jr. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis J. Biol. Chem. 2002, 277, 25474-25479 (Pubitemid 34951861)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.28
, pp. 25474-25479
-
-
Buhman, K.K.1
Smith, S.J.2
Stone, S.J.3
Repa, J.J.4
Wong, J.S.5
Knapp Jr., F.F.6
Burri, B.J.7
Hamilton, R.L.8
Abumrad, N.A.9
Farese Jr., R.V.10
-
13
-
-
77953502272
-
Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice
-
Lee, B.; Fast, A. M.; Zhu, J.; Buhman, K. K. Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice J. Lipid Res. 2010, 51, 1770-1780
-
(2010)
J. Lipid Res.
, vol.51
, pp. 1770-1780
-
-
Lee, B.1
Fast, A.M.2
Zhu, J.3
Buhman, K.K.4
-
14
-
-
80053499230
-
Characterization of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) enzyme of human small intestine
-
Hiramine, Y.; Tanabe, T. Characterization of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) enzyme of human small intestine J. Physiol. Biochem. 2011, 67, 259-264
-
(2011)
J. Physiol. Biochem.
, vol.67
, pp. 259-264
-
-
Hiramine, Y.1
Tanabe, T.2
-
15
-
-
57649233035
-
Acylation of acylglycerols by acyl coenzyme A:diacylglycerol acyltransferase 1 (DGAT1). Functional importance of DGAT1 in the intestinal fat absorption
-
Cheng, D.; Iqbal, J.; Devenny, J.; Chu, C. H.; Chen, L.; Dong, J.; Seethala, R.; Keim, W. J.; Azzara, A. V.; Lawrence, R. M.; Pelleymounter, M. A.; Hussain, M. M. Acylation of acylglycerols by acyl coenzyme A:diacylglycerol acyltransferase 1 (DGAT1). Functional importance of DGAT1 in the intestinal fat absorption J. Biol. Chem. 2008, 283, 29802-29811
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 29802-29811
-
-
Cheng, D.1
Iqbal, J.2
Devenny, J.3
Chu, C.H.4
Chen, L.5
Dong, J.6
Seethala, R.7
Keim, W.J.8
Azzara, A.V.9
Lawrence, R.M.10
Pelleymounter, M.A.11
Hussain, M.M.12
-
16
-
-
0036155661
-
Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands
-
DOI 10.1172/JCI200213880
-
Chen, H. C.; Smith, S. J.; Tow, B.; Elias, P. M.; Farese, R. V., Jr. Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands J. Clin. Invest. 2002, 109, 175-181 (Pubitemid 34083737)
-
(2002)
Journal of Clinical Investigation
, vol.109
, Issue.2
, pp. 175-181
-
-
Chen, H.C.1
Smith, S.J.2
Tow, B.3
Elias, P.M.4
Farese Jr., R.V.5
-
17
-
-
0029030735
-
Aqueous Heck reaction of amino acid derived arenediazonium salts: Semisynthetic modification of phenylalanine and tyrosine
-
Sengupta, S.; Bhattacharyya, S. Aqueous Heck reaction of amino acid derived arenediazonium salts: semisynthetic modification of phenylalanine and tyrosine Tetrahedron Lett. 1995, 36, 4475-4478
-
(1995)
Tetrahedron Lett.
, vol.36
, pp. 4475-4478
-
-
Sengupta, S.1
Bhattacharyya, S.2
-
18
-
-
34248566987
-
A reliable, high-yielding preparation of 2,6-dimethyl-4- hydroxybenzaldehyde
-
Coppola, G. M.; Gong, Y. A reliable, high-yielding preparation of 2,6-dimethyl-4-hydroxybenzaldehyde Org. Prep. Proced. Int. 2007, 39, 199-202
-
(2007)
Org. Prep. Proced. Int.
, vol.39
, pp. 199-202
-
-
Coppola, G.M.1
Gong, Y.2
-
19
-
-
4143104652
-
Ytterbium triflate promoted synthesis of benzimidazole derivatives
-
Curini, M.; Epifano, F.; Montanari, F.; Rosati, O.; Taccone, S. Ytterbium triflate promoted synthesis of benzimidazole derivatives Synlett 2004, 10, 1832-1834 (Pubitemid 39099700)
-
(2004)
Synlett
, Issue.10
, pp. 1832-1834
-
-
Curini, M.1
Epifano, F.2
Montanari, F.3
Rosati, O.4
Taccone, S.5
-
20
-
-
0043240483
-
A practical oxone® - Mediated, high-throughput, solution-phase synthesis of benzimidazoles from 1,2-phenylenediamines and aldehydes and its application to preparative scale synthesis
-
Beaulieu, P. L.; Haché, B.; von Moos, E. A practical oxone-mediated, high-throughput, solution-phase synthesis of benzimidazoles from 1,2-phenylenediamines and aldehydes and its application to preparative scale synthesis Synthesis 2003, 1683-1692 (Pubitemid 36994011)
-
(2003)
Synthesis
, Issue.11
, pp. 1683-1692
-
-
Beaulieu, P.L.1
Hache, B.2
Von Moos, E.3
-
21
-
-
0036293772
-
Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
-
DOI 10.1023/A:1016140429238
-
Tang, F.; Horie, K.; Borchardt, R. T. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? Pharm. Res. 2002, 19, 765-72 (Pubitemid 34686734)
-
(2002)
Pharmaceutical Research
, vol.19
, Issue.6
, pp. 765-772
-
-
Tang, F.1
Horie, K.2
Borchardt, R.T.3
-
22
-
-
79956326438
-
Transporter-mediated drug uptake and efflux: Important determinants of adverse drug reactions
-
Zolk, O.; Fromm, M. F. Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions Clin. Pharmacol. Ther. 2011, 89, 798-805
-
(2011)
Clin. Pharmacol. Ther.
, vol.89
, pp. 798-805
-
-
Zolk, O.1
Fromm, M.F.2
|